 
Regd. Office: E-18, Defence Colony, New Delhi 110024, Ph No.011- 44114411 www.medanta.org, info@medanta.org, CIN: L85110DL2004PLC128319 
November 17, 2025  
 
Ref:- GHL/2025-26/EXCH/83 
 
The General Manager 
Dept. of Corporate Services 
BSE Limited, 
P J Towers, Dalal Street,  
Mumbai - 400 001 
 
 
Scrip Code: 543654 
The Manager 
Listing Department 
National Stock Exchange of India Limited  
Exchange Plaza, C-1, Block G, 
Bandra Kurla Complex, 
Bandra (E), Mumbai - 400 051 
 
Symbol: MEDANTA 
Sub:  Intimation for Schedule of Analysts/Institutional Investors Meetings 
 
Dear Sir(s),  
 
Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure 
Requirements) Regulations, 2015, we would like to inform you that the Companyâ€™s Management will 
meet Investors/Analysts, as per the below schedule: 
 
Date of Meeting Name of Investor/Analyst 
Firm 
Type of 
Meeting 
Place of 
Meeting 
Mode of 
Meeting 
November 20, 2025  Federated Hermes One to One 
Meeting 
Gurugram In person 
November 24 to 26, 
2025  
Jefferies One to One & 
Group Meeting 
Singapore In person 
November 25, 2025 Citi India Pharma & 
Healthcare Tour 
Group Meeting Gurugram In person 
November 27 and 28, 
2025  
Motilal Oswal Financial 
Services 
One to One & 
Group Meeting 
Hong Kong In person 
 
Please note that, no Unpublished Price Sensitive Information is proposed to be shared, thereat. 
 
Note: Please note that the above meet ing(s) is subject to change in case of any unforeseen circumstances, 
on the part of Analysts/Investors/Company. 
 
Kindly take the above on record. 
 
For Global Health Limited     
 
  
 
Rahul Ranjan 
Company Secretary & Compliance Officer 
M. No. A17035 
